Category: Uncategorized

This is the third article in a series on advancements in microbiome research and development.  This installment reviews the area of microbiome research known as the "gut-brain-axis" and therapies related thereto, which have been dubbed "pyschobiotics." Upcoming articles will continue to review important topics in this technology area, and patents of interest. By Jessica Miles*…

Strafford will be offering a webinar/teleconference entitled "Patent Infringement Letters: Considerations and Best Practices for Senders and Recipients — Patent Holder Strategies for Leveraging Letters and Avoiding DJ Actions; Defense and Response Strategies for Alleged Infringers" on June 18, 2015 from 1:00 to 2:30 pm (EDT).  Kirupa Pushparaj, Head IP Counsel, Square and Bobbie Wilson…

The Knowledge Group will offer a live webcast entitled "Patent Term Adjustment: 2015 Final Rules" on May 27, 2015 from 3:00 to 5:00 pm (ET).  Mark Thronson of Dickstein Shapiro LLP; Robert Irani of Bennett Jones; and John C. Donch, Jr. of Volpe and Koenig, PC will review and discuss the nuances and changes in…

By Andrew Williams — The Supreme Court will hear oral arguments in Medtronic Inc. v. Boston Scientific Corp. on Tuesday, November 5, 2013.  The sole issue to be determined is whether the burden of proof shifts in a declaratory judgment action brought by a licensee under MedImmune, such that the licensee has the burden to…

Technology Transfer Tactics will be offering a webinar entitled "Patent 'Trolls' Under Fire: Strategies, Tactics and Legislation Impacting University Patents & Licensing" on October 22, 2013 from 1:00 to 2:00 pm (Eastern).  Scott A. McKeown and Kevin B. Laurence of Oblon Spivak will cover the following topics: • The latest on anti-troll initiatives, including executive…

Practising Law Institute (PLI) will be holding its Fundamentals of Patent Prosecution 2013: A Boot Camp for Claim Drafting & Amendment Writing seminar on May 14-16, 2013 in Chicago, IL, on June 12-14, 2013 in New York, NY, and on July 10-12, 2013 in San Francisco, CA.  The three-day program, which is directed to patent…

By Donald Zuhn — One day after the Supreme Court reversed the Federal Circuit in Mayo Collaborative Services v. Prometheus Laboratories, Inc., finding Prometheus' diagnostic method claims to be invalid for "effectively claim[ing] underlying laws of nature," the U.S. Patent and Trademark Office issued a memorandum to its examining corps providing the Office's preliminary guidance…

By Kevin E. Noonan — One of the longest patent law sagas has apparently reached an end.  As announced by The Medicines Company (MDCO) today, the drug developer has reached a settlement of litigation with APP Pharmaceuticals over Angiomax® (bivalirudin).  Most important for MDCO, the settlement dismisses APP's appeal of the denial of its motion…

By James DeGiulio — Since 2009, we have been tracking the story surrounding Genzyme's enzyme replacement drug Fabrazyme, which started with a problem at Genzyme's manufacturing facilities and led to nationwide shortages of the drug.  These shortages prompted Fabry patients to petition the Department of Health and Human Services to exercise march-in rights under the…

By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) sent a letter today to Attorney General Eric H. Holder, Jr. and Acting Solicitor General Neal K. Kaytal regarding the Supreme Court's request for the government's views on the questions presented by petitioners in Microsoft v. i4i (the Court granted Microsoft's petition for writ of certiorari…